• Sulfo-Cy3 NHS Ester: Advanced Fluorescent Probe Engineering

  2026-06-30

  Explore the scientific advantages of Sulfo-Cy3 NHS Ester, a hydrophilic fluorescent dye optimized for demanding protein labeling and probe engineering. Discover how this reagent empowers high-fidelity conjugation and next-generation bioimaging applications.

• ATM Inhibition Induces Macropinocytosis and Alters Cancer Me

  2026-06-30

  The referenced study uncovers how ATM kinase inhibition promotes metabolic adaptation in cancer cells by stimulating macropinocytosis, thereby enhancing cell survival under nutrient stress. These findings highlight a previously underappreciated link between DNA damage response inhibition and metabolic vulnerability, suggesting new avenues for combination cancer therapies.

• Dual-Emissive Ruthenium Probe Enables Ratiometric Imaging of

  2026-06-29

  This study introduces a dual-emissive tris-heteroleptic ruthenium complex capable of ratiometric imaging detection of amyloid-beta fibrils, with enhanced sensitivity and specificity for Aβ(1-40) aggregates. The findings have implications for improving the accuracy of Alzheimer's disease research assays and early-stage diagnostic workflows.

• Optimizing Immunoassays with Cy3 Goat Anti-Human IgG (H+L) A

  2026-06-29

  This article addresses laboratory challenges in immunofluorescence, IHC, flow cytometry, and ELISA using the Cy3 Goat Anti-Human IgG (H+L) Antibody (SKU K1208). Detailed, scenario-driven Q&A blocks provide evidence-based guidance for protocol optimization, data interpretation, and reagent selection. Researchers will find actionable insights grounded in peer-reviewed literature and validated product specifications.

• 7-Ethyl-10-hydroxycamptothecin: Dual-Mechanism Leverage in C

  2026-06-28

  Explore the mechanistic and translational advances enabled by 7-Ethyl-10-hydroxycamptothecin (SN-38), a potent DNA topoisomerase I inhibitor and apoptosis inducer, with special focus on its dual-action disruption of FUBP1 and topoisomerase I in advanced colon cancer models. This article delivers actionable guidance for translational researchers, highlighting rigorous protocol parameters, breakthrough findings, and strategic lab adoption using APExBIO’s high-purity SKU N2133.

• Ceftazidime: Third-Generation Cephalosporin in Infection Res

  2026-06-27

  Ceftazidime’s robust β-lactamase resistance and unrivaled efficacy against Pseudomonas aeruginosa make it indispensable for Gram-negative infection models and resistance studies. Leverage APExBIO’s high-purity Ceftazidime for reproducible results in multidrug-resistant workflows and translational research.

• Plerixafor (AMD3100): Mechanistic Advances in Cancer and Ste

  2026-06-26

  Explore the multifaceted role of Plerixafor (AMD3100) as a CXCR4 antagonist in cancer metastasis inhibition and hematopoietic stem cell mobilization. This article delivers advanced mechanistic insights and practical guidance distinct from standard protocol overviews.

• Caspase-3 Colorimetric Assay Kit: Precision in Apoptosis Ass

  2026-06-26

  The Caspase-3 Colorimetric Assay Kit from APExBIO empowers researchers to quantify apoptosis with speed and accuracy, leveraging the DEVD-pNA substrate for sensitive detection of caspase-3 activity. Its streamlined protocol and robust colorimetric readout make it indispensable for applications ranging from immune cell signaling to neurodegenerative disease research.

• Capsazepine as a TRPV1 Ion Channel Antagonist in Pain Models

  2026-06-25

  Capsazepine, a synthetic TRPV1 ion channel antagonist from APExBIO, empowers researchers to dissect pain and apoptosis pathways with precision. This guide delivers evidence-backed workflows, troubleshooting strategies, and translational insights for optimizing Capsazepine-driven experiments.

• Cyanidin Chloride: Strategic Leverage for Translational Cell

  2026-06-25

  This thought-leadership article explores the mechanistic depth, translational promise, and experimental nuances of Cyanidin Chloride—a high-purity anthocyanin polyphenolic antioxidant from Bilberry—anchored in recent evidence for oxidative stress and inflammatory skin disease models. By weaving together biological rationale, protocol guidance, and competitive differentiation, the article guides translational researchers in leveraging Cyanidin Chloride’s unique properties for robust, reproducible research and next-generation therapeutic discovery.

• Network Pharmacology Reveals SFI Blocks Glioma via SRC/PI3K/

  2026-06-24

  This study systematically investigated how Shenqi Fuzheng injection (SFI) inhibits glioma proliferation and migration by targeting the SRC/PI3K/AKT signaling pathway, utilizing integrated network pharmacology and experimental validation. The findings clarify SFI’s anti-angiogenic and anti-proliferative mechanisms, informing the development of targeted therapies for malignant gliomas.

• HyperScribe T7 High Yield RNA Synthesis Kit Plus: Precision

  2026-06-23

  The HyperScribe T7 High Yield RNA Synthesis Kit Plus empowers researchers to generate capped, labeled, or biotinylated RNA at scale for advanced mRNA rescue, RNAi, and probe-based workflows. Its robust yields, protocol flexibility, and streamlined troubleshooting make it the tool of choice for high-fidelity RNA synthesis in translational and functional genomics research.

• ER Stress and Cytokine Storms Drive Pro-Metastatic Tumor Sta

  2026-06-23

  Conod et al. (2022) reveal that tumor cells surviving near-lethal stress acquire stable pro-metastatic states, termed PAMEs, through ER stress and nuclear reprogramming. These findings underscore the paradoxical risk of metastasis following cell-death-inducing therapies and highlight new molecular targets for intervention.

• VX-661: Applied Workflows for F508del CFTR Correction in Res

  2026-06-22

  VX-661 (F508del CFTR corrector) empowers cystic fibrosis researchers to restore chloride channel function in vitro using robust, evidence-based workflows. Recent calnexin-dependent findings and protocol refinements offer new precision for variant-specific CFTR rescue and mechanistic studies.

• Protease and Phosphatase Inhibitor Cocktail: Precision in St

  2026-06-22

  Unlock precise protein extraction from stem cell and tissue samples using the Protease and Phosphatase Inhibitor Cocktail (EDTA Free, 100X in ddH2O). Discover how this advanced reagent ensures reliable phosphorylation analysis and assay fidelity, with a unique focus on chamber-specific cardiomyocyte research.

15627 records 1/1042 page Next 12345 下5页 Last page